Literature DB >> 6317805

Enolase isoenzymes in the cerebrospinal fluid of patients with diseases of the nervous system.

J A Royds, G A Davies-Jones, N A Lewtas, W R Timperley, C B Taylor.   

Abstract

Alpha and gamma enolase isoenzymes have been studied in 212 patients with a variety of neurological diseases. The results show that these proteins are sensitive markers of tissue damage which enable a distinction to be made between the involvement of glial and neuronal components.

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6317805      PMCID： PMC491739          DOI： 10.1136/jnnp.46.11.1031

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


  12 in total

1.  Neurone-specific enolase is a molecular marker for peripheral and central neuroendocrine cells.

Authors:  D Schmechel; P J Marangos; M Brightman
Journal:  Nature       Date:  1978 Dec 21-28       Impact factor: 49.962

2.  Enolase isoenzymes in rat tissues. Electrophoretic, chromatographic, immunological and kinetic properties.

Authors:  C C Rider; C B Taylor
Journal:  Biochim Biophys Acta       Date:  1974-09-13

Review 3.  The neurobiology of the brain enolases.

Authors:  P J Marangos; D Schmechel
Journal:  Essays Neurochem Neuropharmacol       Date:  1980

Review 4.  Toxic substances and the nervous system: the role of clinical observation.

Authors:  P M Le Quesne
Journal:  J Neurol Neurosurg Psychiatry       Date:  1981-01       Impact factor: 10.154

5.  Increased nervous system-specific enolases in rat plasma and cerebrospinal fluid in bilirubin encephalopathy detected by an enzyme immunoassay.

Authors:  R Semba; K Kato
Journal:  J Neurochem       Date:  1982-08       Impact factor: 5.372

6.  Serum neuron-specific enolase: a marker for disease extent and response to therapy of small-cell lung cancer.

Authors:  D N Carney; P J Marangos; D C Ihde; P A Bunn; M H Cohen; J D Minna; A F Gazdar
Journal:  Lancet       Date:  1982-03-13       Impact factor: 79.321

7.  The labelling of proteins to high specific radioactivities by conjugation to a 125I-containing acylating agent.

Authors:  A E Bolton; W M Hunter
Journal:  Biochem J       Date:  1973-07       Impact factor: 3.857

8.  Brain endolases as specific markers of neuronal and glial cells.

Authors:  D Schmechel; P J Marangos; A P Zis; M Brightman; F K Goodwin
Journal:  Science       Date:  1978-01-20       Impact factor: 47.728

9.  Enolase isoenzymes. III. Chromatographic and immunological characteristics of rat brain enolase.

Authors:  L Fletcher; C C Rider; C B Taylor
Journal:  Biochim Biophys Acta       Date:  1976-11-08

10.  Brain levels of neuron-specific and nonneuronal enolase in Huntington's disease.

Authors:  P J Marangos; S M Paul
Journal:  J Neurochem       Date:  1981-11       Impact factor: 5.372
View more
  15 in total

1.  S-100 protein in cerebrospinal fluid after aneurysmal subarachnoid haemorrhage: relation to functional outcome, late CT and SPECT changes, and signs of higher cortical dysfunction.

Authors:  H G Hårdemark; O Almqvist; T Johansson; S Påhlman; L Persson
Journal:  Acta Neurochir (Wien)       Date:  1989       Impact factor: 2.216

2.  Secretion of neuron-specific enolase, prolactin, growth hormone, luteinising hormone and follicle stimulating hormone by "functionless" and endocrine-active pituitary tumours in vitro.

Authors:  N F Lawton; A J Evans; J D Pickard; S Perry; B Davies
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-05       Impact factor: 10.154

3.  The cytopathogenic agent in CSF: evidence for a relationship with enolase levels.

Authors:  G R Taylor; G W Roberts; T J Crow; J A Royds; S J Gamble; C B Taylor; G I Carter; W R Timperley
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-03       Impact factor: 10.154

4.  High neuron-specific enolase level of cerebrospinal fluid in the early stage of Creutzfeldt-Jakob disease.

Authors:  Y Wakayama; S Shibuya; J Kawase; F Sagawa; Y Hashizume
Journal:  Klin Wochenschr       Date:  1987-08-17

5.  Clinico-pathophysiological features of acute autonomic and sensory neuropathy: a long-term follow-up study.

Authors:  T Yasuda; G Sobue; K Mokuno; S Hakusui; T Ito; Y Hirose; T Yanagi
Journal:  J Neurol       Date:  1995-10       Impact factor: 4.849

6.  Neuron specific enolase (NSE) and thymidine kinase (TK) as markers in biological fluids of brain tumor patients.

Authors:  A Boiardi; L Munari; A Silvani; C L Solero; E Bombardieri
Journal:  Ital J Neurol Sci       Date:  1990-08

7.  Elevated levels of the alpha subunit of GTP-binding protein Go in cerebrospinal fluid of patients with neurological disorders.

Authors:  T Murayama; A Takahashi; T Asano; K Kato
Journal:  J Mol Neurosci       Date:  1989       Impact factor: 3.444

8.  Cerebrospinal fluid neuron-specific enolase is decreased in multi-infarct dementia, but unchanged in Alzheimer's disease.

Authors:  R Sulkava; L Viinikka; T Erkinjuntti; R Roine
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-04       Impact factor: 10.154

9.  Cerebrospinal fluid enolase isoenzymes and neurotoxicity in early treatment of lymphoblastic leukaemia.

Authors:  J A Royds; J S Lilleyman; W R Timperley; C B Taylor
Journal:  Arch Dis Child       Date:  1984-03       Impact factor: 3.791

Review 10.  Clinical neuropathology practice guide 5-2013: markers of neuronal maturation.

Authors:  Harvey B Sarnat
Journal:  Clin Neuropathol       Date:  2013 Sep-Oct       Impact factor: 1.368
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.